Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06888479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimal Timing of Hepatitis B Vaccination After Transplants

Name: Optimal Timing of Hepatitis B Vaccination After Transplants — clinical trial record (NCT06888479)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 3

SponsorInstitute of Hematology & Blood Diseases Hospital, China

Started2025-06-01

View on ClinicalTrials.gov ↗

Institute of Hematology & Blood Diseases Hospital, China

318 trials monitored

See 9 trials at risk

The investigators aim to perform a randomized clinical trial to determine the optimal timing of hepatitis B vaccination after hematopoietic cell transplantation (HCT) through evaluating the immunity effect of two different vaccination schedules (initiated at 3 or 6 months after transplantation) in patients with different immune reconstitution status.

Trial Details

NCT Number	NCT06888479
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Transplant-Related Disorder, Hepatitis B Virus Infection, Vaccine Reaction
Enrollment	1,500 participants
Start Date	2025-06-01
Primary Completion	2028-06-01 (estimated)
Study Completion	2029-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-03-21